TITLE

The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer

AUTHOR(S)
Koga, Yasuo; Kitajima, Yoshihiko; Miyoshi, Atsushi; Sato, Ken; Sato, Seiji; Miyazaki, Kohji
PUB. DATE
February 2006
SOURCE
Journal of Gastroenterology;Feb2006, Vol. 41 Issue 2, p133
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the results of a study concerning the significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer. The results suggest that the assessment of CHFR methylation status may be a clinically useful to predict the response of gastric cancers to treatment with microtubule inhibitors.
ACCESSION #
20279884

 

Related Articles

  • Frequent epigenetic inactivation of secreted frizzled-related protein 2 (SFRP2) by promoter methylation in human gastric cancer. Cheng, Y. Y.; Yu, J.; Wong, Y. P.; Man, E. P. S.; To, K. F.; Jin, V. X.; Li, J.; Tao, Q.; Sung, J. J. Y.; Chan, F. K. L.; Leung, W. K. // British Journal of Cancer;10/8/2007, Vol. 97 Issue 7, p895 

    The role of secreted frizzled-related protein (SFRP) genes in gastric cancer remains largely unknown. We determined the frequency and functional significance of SFRPs hypermethylation in human gastric cancer. The expression and methylation status of four SFRP members (SFRP1, 2, 4, and 5) in...

  • A phase II trial of ixabepilone in Asian patients with advanced gastric cancer previously treated with fluoropyrimidine-based chemotherapy. Kim, Yeul; Muro, Kei; Yasui, Hirofumi; Chen, Jen-Shi; Ryu, Min-Hee; Park, Se-Hoon; Chu, Kent-Man; Choo, Su-Pin; Sanchez, Teresa; DelaCruz, Christine; Mukhopadhyay, Pralay; Lainas, Ioannis; Li, Chung-Pin // Cancer Chemotherapy & Pharmacology;Oct2012, Vol. 70 Issue 4, p583 

    Purpose: The highest rates of gastric cancer occur in Eastern Asia. Fluoropyrimidine-based therapy is used initially in unresectable and metastatic disease, but no single standard of care exists following disease progression. Ixabepilone, an epothilone B analog, is a non-taxane...

  • Proton-Pump Inhibitors May Mask Stomach Cancer. Cerrato, Paul L.; Struble, Jennifer // RN;Oct98, Vol. 61 Issue 10, p82 

    Presents information from a study conducted by British physicians on proton-pump inhibitors which can mask the signs of stomach cancer. Pain which is relieved by using the inhibitors; How the use of these inhibitors affect the diagnosis of tumors in the early stages.

  • Concomitant RASSF1A hypermethylation and KRAS/BRAF mutations occur preferentially in MSI sporadic colorectal cancer. Oliveira, Carla; Velho, Sérgia; Domingo, Enric; Preto, Ana; Hofstra, Robert M. W.; Hamelin, Richard; Yamamoto, Hiroyuki; Seruca, Raquel; Schwartz Jr., Simo // Oncogene;11/17/2005, Vol. 24 Issue 51, p7630 

    Methylation-associated inactivation of RASSF1A has frequently been observed in several human malignancies including sporadic colorectal and gastric cancer. However, nothing is known about the RASSF1A methylation status in the setting of MMR-deficient gastrointestinal tumours. In this study, we...

  • Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer. Yoda, Yukie; Takeshima, Hideyuki; Niwa, Tohru; Kim, Jeong; Ando, Takayuki; Kushima, Ryoji; Sugiyama, Toshiro; Katai, Hitoshi; Noshiro, Hirokazu; Ushijima, Toshikazu // Gastric Cancer;Jan2015, Vol. 18 Issue 1, p65 

    Background: The profiles of genetic and epigenetic alterations in cancer-related pathways are considered to be useful for selection of patients likely to respond to specific drugs, including molecular-targeted and epigenetic drugs. In this study, we aimed to characterize such profiles in gastric...

  • SULF2 Methylation Is Associated with In Vitro Cisplatin Sensitivity and Clinical Efficacy for Gastric Cancer Patients Treated with a Modified FOLFOX Regimen. Shen, Jie; Wei, Jia; Wang, Hao; Yang, Yang; Yue, Guofeng; Wang, Lin; Yu, Lixia; Xie, Li; Sun, Xia; Bian, Xinyu; Zou, Zhengyun; Qian, Xiaoping; Guan, Wenxian; Liu, Baorui // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Objective: Biomarkers capable of discriminating the patients who are likely to respond to certain chemotherapeutic agents could improve the clinical efficiency. The sulfatases(SULFs) play a critical role in the pathogenesis of a variety of human cancers. Here, we focused our investigation on the...

  • Epigenetics modulates the effect of chemotherapy on gastric cancer. Watanabe, Yoshiyuki; Itoh, Fumio // Journal of Gastroenterology;Feb2006, Vol. 41 Issue 2, p180 

    The article comments on the function of epigenetics in modulating the effect of chemotherapy on gastric cancer. The widely accepted administration of fluorouracil, doxorubicin and high-dose methotrexate has failed to demonstrate any superiority over other combination regimens in clinical trials....

  • Lessons in Treatment of Gastric Cancer: Viewpoint of a UK Surgeon. Gupta, Ramesh // Japanese Journal of Clinical Oncology;Aug2000, Vol. 30 Issue 8 

    Focuses on gastric cancer treatment from the viewpoint of a British surgeon. Preoperative assessment; Operative technique; Postoperative care.

  • Improving the results of treating gastric cancer . J.D., Peter; Bancewicz, John // BMJ: British Medical Journal (International Edition);7/29/89, Vol. 298 Issue 6694, p278 

    Focuses on the improvement in the results of treating gastric cancer. Use of extended lymphadenectomy; Difference between the occurrence of the diseases in Great Britain and Japan; Diagnosis of the disease.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics